Temedica’s Post

As diabetes prevalence continues to rise worldwide, routine HbA1c testing plays a crucial role in effective diabetes management. Patients are increasingly recognizing the significance of regular testing, leading to a surge in demand for less-invasive and accurate testing methods. Some of the key players operating in the market are Abbott, Bio-Rad Laboratories, ARKRAY,Inc., Danaher Corporation, Roche, Siemens Healthineers, Transasia Bio-Medicals Ltd., Trinity Biotech, EKF Diagnostics, Beckman Coulter Diagnostics, and Randox among others. Unlock valuable market insights, request your sample report now https://lnkd.in/dBR-hGP8 Join us in the journey towards better diabetes management and improved healthcare outcomes! 💪 #HealthcareInnovation #DiabetesManagement #HbA1cTesting #GlobalHealthcare #HealthTech #MedicalInnovation #HealthcareIndustry #HealthcareTechnology #MedicalDevices #HealthAwareness #PatientCare #HealthEquity #HealthForAll #DigitalHealth #InnovationInHealthcare #HealthcareTrends #MedicalResearch #GlobalHealth #HealthcareProviders #PublicHealth #HealthyLiving #DiabetesAwareness #HealthAndWellness #HealthcareSolutions #HbA1c #GlycatedHemoglobin #DiabetesTesting #BloodSugarControl #A1cTest #DiabetesCare #GlucoseMonitoring #Endocrinology #DiabetesPrevention #BloodSugarLevels #Type1Diabetes #Type2Diabetes #InsulinResistance #MetabolicHealth #HealthyBloodSugar #ContinuousGlucoseMonitoring #HealthCheck #PreventiveCare

The Global HbA1c Testing Market is projected to soar with a remarkable growth rate of 9-12% by 2028! 📈 As diabetes prevalence continues to rise worldwide, routine HbA1c testing plays a crucial role in effective diabetes management. Patients are increasingly recognizing the significance of regular testing, leading to a surge in demand for less-invasive and accurate testing methods. Some of the key players operating in the market are Abbott, Bio-Rad Laboratories, ARKRAY,Inc., Danaher Corporation, Roche, Siemens Healthineers, Transasia Bio-Medicals Ltd., Trinity Biotech, EKF Diagnostics, Beckman Coulter Diagnostics, and Randox among others. Unlock valuable market insights, request your sample report now https://lnkd.in/dBR-hGP8 Join us in the journey towards better diabetes management and improved healthcare outcomes! 💪 #HealthcareInnovation #DiabetesManagement #HbA1cTesting #GlobalHealthcare #HealthTech #MedicalInnovation #HealthcareIndustry #HealthcareTechnology #MedicalDevices #HealthAwareness #PatientCare #HealthEquity #HealthForAll #DigitalHealth #InnovationInHealthcare #HealthcareTrends #MedicalResearch #GlobalHealth #HealthcareProviders #PublicHealth #HealthyLiving #DiabetesAwareness #HealthAndWellness #HealthcareSolutions #HbA1c #GlycatedHemoglobin #DiabetesTesting #BloodSugarControl #A1cTest #DiabetesCare #GlucoseMonitoring #Endocrinology #DiabetesPrevention #BloodSugarLevels #Type1Diabetes #Type2Diabetes #InsulinResistance #MetabolicHealth #HealthyBloodSugar #ContinuousGlucoseMonitoring #HealthCheck #PreventiveCare

Check out these upcoming webinars …valuable information that women managing diabetes need!

🚨 Exciting Development in Diabetes Care! 🚨 Zydus Group has partnered with CVS Caremark to include Zituvio™, Zituvimet™, and Zituvimet™ XR in its formulary. These innovative therapies aim to provide better glycemic control for adults with type 2 diabetes, making quality healthcare more accessible. This collaboration highlights Zydus Group commitment to addressing lifestyle diseases while reinforcing its footprint in the $10B U.S. diabetes market. 💡 Insight: Strategic partnerships are shaping the future of affordable healthcare globally. Follow Harshal Jain for the latest insights into the healthcare world! #Healthcare #PharmaUpdates #IndiaPharma #PharmaceuticalIndustry #Harshal #HJ

All three #GLP-1s — #semaglutide, #tirzepatide, and liraglutide — offer significant benefits in managing type 2 diabetes and #weightloss but differ in their administration schedules, efficacy, and additional benefits. We are breaking down how they differ in our latest insight article.

Looking to improve patient outcomes in diabetes care? Check out this informative webinar on Basal Insulin: Practical and Innovative Strategies for Adherence. #DiabetesCare #BasalInsulin #HealthcareProfessionals #Webinar

The landscape of #DigitalHealth solutions for #DiabetesManagement is rapidly evolving, and I was excited to read the latest report comparing different digital solutions. With almost one in ten people globally affected by type 2 diabetes, finding effective ways to manage this condition is more crucial than ever. The report reviews the efficacy of eight digital diabetes management tools aimed at improving glycemic control in patients. Key Takeaways: 1️⃣ Remote Patient Monitoring: While aiming to enhance glycemic control, these solutions didn't demonstrate significant clinical benefits over usual care. 2️⃣ Behavior and Lifestyle Modification: Despite incorporating diverse programs, the evidence suggests minimal and short-term improvements in glycemic control. 3️⃣ Nutritional Ketosis: Exceptions were observed, particularly for individuals with higher HbA1c levels and those pursuing diabetes remission through nutritional ketosis, however, the quality of evidence for this was low. You can read the report here: https://lnkd.in/d8pxKpTr Let's continue the conversation towards better healthcare outcomes! #HealthcareInnovation

All three #GLP-1s — #semaglutide, #tirzepatide, and liraglutide — offer significant benefits in managing type 2 diabetes and #weightloss but differ in their administration schedules, efficacy, and additional benefits. We are breaking down how they differ in our latest insight article.

I'm delighted to announce that I've successfully completed the two-day World Diabetes Day webinar organized by MEDODRIX . This webinar provides valuable insights into the various types of insulin, as well as how to administer it and manage diabetes. Additionally, it provided a great grasp of how to bridge the gap between Research and clinical practice in diabetes.Thank you Dr.Mothish Waran sir, for providing such wonderful sessions. #Research #Diabetes #PharmD #ClinicalPractice #PharmacyPractice #Worlddiabetesday #Therapeutics

Introducing a game-changing solution for diabetes management! Hedia Diabetes Assistant integrated with Glooko® is now available in the United Kingdom. The integration streamlines Multiple Daily Insulin Therapy, providing People with Diabetes with a single, user-friendly app for reviewing data and receiving personalised bolus insights, making daily management easier. Key Benefits for People with Diabetes: ●     Ease the Burden of Multiple Daily Insulin Therapy: Tailored insulin dose recommendations simplify daily diabetes management with accurate dose calculations and fewer human errors. ●     Improved Outcomes: Help to achieve better diabetes management, with improvements in estimated A1c (eA1c) for people with suboptimal glycemic control.* Key Benefits for Healthcare Professionals: ●     Consolidated Patient Data for Better Clinical Decisions: With Glooko®, access data on insulin doses, glucose levels, and carbohydrate intake, integrated from CGMs, BGMs, and Smart Insulin Pens for informed decision-making (remotely or during consultation). Interested in enhancing patient care? Learn more about Hedia licences: https://bit.ly/4j5vIZu. #DiabetesCare #HealthcareInnovation #Glooko #Hedia #InsulinManagement #HealthTech #BetterTogether *Changes in eA1C in a type 1 diabetes population after 41 weeks use of Hedia Diabetes Assistant.